PMC:7200337 / 53582-53841 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T532","span":{"begin":22,"end":36},"obj":"Body_part"}],"attributes":[{"id":"A532","pred":"fma_id","subj":"T532","obj":"http://purl.org/sig/ont/fma/fma62871"}],"text":"High-dose intravenous immunoglobulin (IVIg), which may blunt ADE, has been trialed in COVID-19 patients (Cao et al., 2020b, Shao et al., 2020), but further studies are needed to determine the extent to which IVIg is safe or beneficial in SARS-CoV-2 infection."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T343","span":{"begin":61,"end":64},"obj":"Disease"},{"id":"T344","span":{"begin":86,"end":94},"obj":"Disease"},{"id":"T345","span":{"begin":238,"end":246},"obj":"Disease"},{"id":"T346","span":{"begin":249,"end":258},"obj":"Disease"}],"attributes":[{"id":"A343","pred":"mondo_id","subj":"T343","obj":"http://purl.obolibrary.org/obo/MONDO_0019383"},{"id":"A344","pred":"mondo_id","subj":"T344","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A345","pred":"mondo_id","subj":"T345","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A346","pred":"mondo_id","subj":"T346","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"High-dose intravenous immunoglobulin (IVIg), which may blunt ADE, has been trialed in COVID-19 patients (Cao et al., 2020b, Shao et al., 2020), but further studies are needed to determine the extent to which IVIg is safe or beneficial in SARS-CoV-2 infection."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T661","span":{"begin":66,"end":69},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"}],"text":"High-dose intravenous immunoglobulin (IVIg), which may blunt ADE, has been trialed in COVID-19 patients (Cao et al., 2020b, Shao et al., 2020), but further studies are needed to determine the extent to which IVIg is safe or beneficial in SARS-CoV-2 infection."}

{"project":"LitCovid-PubTator","denotations":[{"id":"1736","span":{"begin":199,"end":201},"obj":"Gene"},{"id":"1737","span":{"begin":175,"end":177},"obj":"Gene"},{"id":"1742","span":{"begin":95,"end":103},"obj":"Species"},{"id":"1744","span":{"begin":86,"end":94},"obj":"Disease"},{"id":"1745","span":{"begin":238,"end":258},"obj":"Disease"}],"attributes":[{"id":"A1736","pred":"tao:has_database_id","subj":"1736","obj":"Gene:6999"},{"id":"A1737","pred":"tao:has_database_id","subj":"1737","obj":"Gene:6999"},{"id":"A1742","pred":"tao:has_database_id","subj":"1742","obj":"Tax:9606"},{"id":"A1744","pred":"tao:has_database_id","subj":"1744","obj":"MESH:C000657245"},{"id":"A1745","pred":"tao:has_database_id","subj":"1745","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"High-dose intravenous immunoglobulin (IVIg), which may blunt ADE, has been trialed in COVID-19 patients (Cao et al., 2020b, Shao et al., 2020), but further studies are needed to determine the extent to which IVIg is safe or beneficial in SARS-CoV-2 infection."}

{"project":"LitCovid-sentences","denotations":[{"id":"T294","span":{"begin":0,"end":259},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"High-dose intravenous immunoglobulin (IVIg), which may blunt ADE, has been trialed in COVID-19 patients (Cao et al., 2020b, Shao et al., 2020), but further studies are needed to determine the extent to which IVIg is safe or beneficial in SARS-CoV-2 infection."}